HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kay-Uwe Wagner Selected Research

Tsg101 protein

2/2020The Multifaceted Roles of the Tumor Susceptibility Gene 101 (TSG101) in Normal Development and Disease.
1/2019Tsg101 positively regulates physiologic-like cardiac hypertrophy through FIP3-mediated endosomal recycling of IGF-1R.
1/2003Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues.
11/2002Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kay-Uwe Wagner Research Topics

Disease

33Neoplasms (Cancer)
01/2022 - 05/2002
21Breast Neoplasms (Breast Cancer)
01/2022 - 05/2002
7Carcinogenesis
01/2022 - 05/2002
7Neoplasm Metastasis (Metastasis)
09/2021 - 03/2008
5Pancreatic Neoplasms (Pancreatic Cancer)
06/2021 - 10/2012
4Inflammation (Inflammations)
11/2018 - 12/2015
4Fatty Liver
01/2017 - 04/2011
2Atherosclerosis
01/2022 - 07/2017
2Anemia
01/2017 - 02/2013
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 10/2011
2Disease Progression
11/2016 - 12/2015
2Infections
11/2010 - 11/2004
2Carcinoma (Carcinomatosis)
12/2008 - 03/2008
1Primitive Neuroectodermal Tumors (PNET)
10/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2021
1Retinoblastoma (Glioblastoma, Retinal)
01/2020
1Hypertrophy
01/2019
1Cardiomegaly (Heart Hypertrophy)
01/2019
1Adenoid Cystic Carcinoma (Cylindroma)
01/2018
1Rare Diseases (Rare Disease)
01/2018
1Primary Myelofibrosis (Myelosclerosis)
01/2017
1Portal Hypertension
01/2017
1End Stage Liver Disease
01/2017
1Peritonitis
01/2017
1Varicose Veins (Varicose Vein)
01/2017
1Ascites
01/2017

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2004
5LigandsIBA
10/2021 - 05/2002
5Phenobarbital (Luminal)FDA Link
10/2021 - 03/2014
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2021 - 09/2007
5CytokinesIBA
11/2018 - 11/2010
4Janus Kinase 2IBA
01/2022 - 08/2009
4Tsg101 proteinIBA
02/2020 - 11/2002
4Janus KinasesIBA
11/2018 - 01/2011
4Growth Hormone (Somatotropin)IBA
07/2017 - 04/2011
4STAT5 Transcription FactorIBA
10/2016 - 05/2002
3Messenger RNA (mRNA)IBA
01/2022 - 05/2015
3Biological ProductsIBA
01/2021 - 04/2014
3CarcinogensIBA
01/2021 - 05/2002
3Oncogene Proteins (Oncogene Protein)IBA
02/2020 - 01/2012
3Small Interfering RNA (siRNA)IBA
01/2019 - 05/2013
3Angiotensin IIIBA
01/2017 - 06/2011
3Phosphotransferases (Kinase)IBA
12/2016 - 01/2011
3Tyrosine (L-Tyrosine)FDA Link
11/2016 - 09/2007
3CyclinsIBA
01/2014 - 08/2009
3Cyclin D1IBA
01/2014 - 08/2009
2ruxolitinibIBA
01/2022 - 02/2013
2Estrogen ReceptorsIBA
09/2021 - 12/2019
2Endosomal Sorting Complexes Required for TransportIBA
01/2019 - 11/2016
2Insulin-Like Growth Factor I (IGF-1)IBA
01/2019 - 07/2017
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2019 - 02/2004
2Janus Kinase 1IBA
11/2018 - 01/2017
2ErythropoietinFDA Link
01/2017 - 02/2013
2IronIBA
01/2017 - 06/2011
2MucinsIBA
12/2015 - 10/2012
2Hormones (Hormone)IBA
04/2014 - 08/2013
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
04/2014 - 02/2004
2Cyclin D3IBA
01/2014 - 12/2011
2LipidsIBA
08/2013 - 02/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2011 - 07/2011
1CholesterolIBA
01/2022
1Glucose (Dextrose)FDA LinkGeneric
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Apolipoproteins E (ApoE)IBA
01/2022
1Liver X ReceptorsIBA
01/2022
1TamoxifenFDA LinkGeneric
10/2021
1Recombinases (Recombinase)IBA
10/2021
1Cre recombinaseIBA
10/2021
1Mechanistic Target of Rapamycin Complex 2IBA
10/2021
1KPT-9274IBA
10/2021
1EverolimusFDA Link
10/2021
1EnzymesIBA
10/2021
1p21-Activated KinasesIBA
10/2021
1NAD (NADH)IBA
10/2021
1Niacinamide (Nicotinamide)FDA LinkGeneric
10/2021
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
10/2021
1TransferasesIBA
10/2021
1CateninsIBA
10/2021
1Pharmaceutical PreparationsIBA
09/2021
1Estrogens (Estrogen)FDA Link
09/2021
1ProlactinIBA
09/2021
1MicroRNAs (MicroRNA)IBA
06/2021
1Biomarkers (Surrogate Marker)IBA
06/2021
1ClaudinsIBA
01/2021
1Pertussis ToxinIBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
12/2019
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2019
1Monensin (Coban)IBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2018
1rho-Associated KinasesIBA
01/2017
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
01/2017
1Rho Guanine Nucleotide Exchange FactorsIBA
01/2017
1Methionine (L-Methionine)FDA Link
01/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1HepcidinsIBA
01/2017

Therapy/Procedure

12Therapeutics
10/2021 - 08/2009
3Drug Therapy (Chemotherapy)
10/2021 - 11/2004
1Precision Medicine
09/2021
1Heterologous Transplantation (Xenotransplantation)
01/2021
1Ligation
01/2017